Everolimus Beyond Progress for Patients Who Had Progress Under Everolimus and Exemestane
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Everolimus|DRUG: Everolimus-placebo
Sponsor: German Breast Group
Collaborators: Novartis